RSNA News: PI-RADS v2 Effective in Predicting Prostate Cancer

April 1, 2017
PI-RADS

Experts, Clare M. Tempany-Afdhal, MD, Sung Yoon Park, MD, PhD, and Jelle Barentsz, MD, PhD, weigh in on PI-RADS v2 — a simplified scoring system focusing on the detection and exclusion of clinically significant prostate cancer. More...

See also: news, 2017